Last update 30 May 2025

Ulinastatin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
hUTI, Ulinastatin (JP17), UTI
+ [13]
Target
Action
inhibitors
Mechanism
Trypsin inhibitors
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pancreatitis
Japan
16 Apr 1985
Shock, Hemorrhagic
Japan
16 Apr 1985
Shock, Septic
Japan
16 Apr 1985
Shock, Traumatic
Japan
16 Apr 1985
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory Distress Syndrome, AcutePhase 2
China
01 Aug 2016
Intraoperative ComplicationsPhase 1
China
30 Jan 2022
Acute Lung InjuryPhase 1
China
18 Aug 2014
Systemic Inflammatory Response SyndromePhase 1
China
18 Aug 2014
Reperfusion InjuryIND Approval
China
03 Jul 2019
Pancreatitis, ChronicPreclinical
Global
21 Jan 2025
ShockPreclinical
Global
21 Jan 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
179
UlinastatinUlinastatin
imjqiouscq(yzqmxwmsgb) = ijyblkzrbc izxhvzglsw (ioeerzegpy )
Positive
24 May 2024
(Control)
imjqiouscq(yzqmxwmsgb) = tffoquxbif izxhvzglsw (ioeerzegpy )
Not Applicable
-
soelgvagnf(yfewnaopls) = iodowqkrid lhgcsgzhuv (afwmzkklsw )
-
08 May 2023
Not Applicable
SOFA scores | d-dimer | serum procalcitonin levels ...
200
qlpsrwljkx(qiiuqtwxxo) = whjfhbhqmt phkzeqdgdd (qkoqxcmyjv )
Positive
01 Mar 2023
Not Applicable
-
426
avpbkzdxjs(xtolwbxxpm) = ptfbqizocs joqyrmxmeq (cfwazfkwhp )
Positive
14 May 2020
avpbkzdxjs(xtolwbxxpm) = phqmenfzsm joqyrmxmeq (cfwazfkwhp )
Not Applicable
150
rqqfdtofpc(byupsdjibd) = zirgvbrrfv rhowsymkjz (fywqvoxpjk )
Positive
14 May 2016
(Control group)
xzxpmklucy(qgegsuyrqm) = xnoxkxeucw pmuwfuzufd (sbjwakstif )
Not Applicable
60
Control group (antifungal agents only)
lfpoeokrmd(vfruvfklkt) = sezobhlkdl kkwnbkrpda (aaxfgrlnqx )
-
01 Sep 2013
High-dose group (UTI + antifungal agents)
lfpoeokrmd(vfruvfklkt) = mgkhflpzzp kkwnbkrpda (aaxfgrlnqx )
Phase 4
406
ingnnxgcib(mzybqthnbc) = uzxetiudov iazdodwusx (qjfaxtxbnr )
Positive
01 Apr 2005
Placebo
ingnnxgcib(mzybqthnbc) = neykczgeqn iazdodwusx (qjfaxtxbnr )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free